IFIT3 mediates TBK1 phosphorylation to promote activation of pDCs and exacerbate systemic sclerosis in mice

Abstract

	•This study elucidates the pivotal role of plasmacytoid dendritic cells (pDCs) in systemic sclerosis (SSc).
	•This study identified the key regulatory gene involved in systemic sclerosis (SSc) as IFIT3.
	•This study has found that IFIT3 functions as an upstream regulatory factor, activating TBK1.
	•This study provides Evidence of the regulatory effects of the IFIT3/TBK1 pathway on plasmacytoid dendritic cells (pDCs).
	•This study validated the therapeutic potential using the IFIT3-/- mouse model.

Keywords

CRISPR/Cas9 / fibrosis / IFIT3/TBK1 signalling pathway / pDCs activation / scRNA-seq / systemic sclerosis

References

[1] BobeicaC, Niculet E, MusatCL, et al. Paraclinical aspects in systemic sclerosis. Int J Gen Med. 2022; 15: 4391-4398.

[2] JerjenR, Nikpour M, KriegT, DentonCP, Saracino AM. Systemic sclerosis in adults. Part I: clinical features and pathogenesis. J Am Acad Dermatol. 2022; 87(5): 937-954.

[3] DentonCP, KhannaD. Systemic sclerosis. Lancet. 2017; 390(10103): 1685-1699.

[4] StochmalA, Czuwara J, TrojanowskaM, RudnickaL. Antinuclear antibodies in systemic sclerosis: an update. Clin Rev Allergy Immunol. 2020; 58(1): 40-51.

[5] SobolewskiP, Maślińska M, WieczorekM, et al. Systemic sclerosis—multidisciplinary disease: clinical features and treatment. Reumatologia. 2019; 57(4): 221-233.

[6] TuhyT, Hassoun PM. Clinical features of pulmonary arterial hypertension associated with systemic sclerosis. Front Med (Lausanne). 2023; 10: 1264906.

[7] KoppJB, AndersHJ, SusztakK, et al. Podocytopathies. Nat Rev Dis Primers. 2020; 6(1): 68.

[8] BaharomF, Ramirez-Valdez RA, KhalilnezhadA, et al. Systemic vaccination induces CD8⁺ T cells and remodels the tumor microenvironment. Cell. 2022; 185(23): 4317-4332.

[9] FangD, ChenB, LescoatA, Khanna D, MuR. Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis. Nat Rev Rheumatol. 2022; 18(12): 683-693.

[10] FargeD, LoiselS, LansiauxP, Tarte K. Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev. 2021; 20(3): 102755.

[11] WorrellJC, O’Reilly S. Bi-directional communication: conversations between fibroblasts and immune cells in systemic sclerosis. J Autoimmun. 2020; 113: 102526.

[12] Lee-SundlovMM, BurnsRT, KimTO, et al. Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count. Blood. 2021; 138(23): 2408-2424.

[13] SilvaIS, Ferreira BH, AlmeidaCR. Molecular mechanisms behind the role of plasmacytoid dendritic cells in systemic sclerosis. Biology (Basel). 2023; 12(2): 285.

[14] ChaudharyV, Ah Kioon MD, HwangSM, et al. Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses. J Exp Med. 2022; 219(11): e20221085.

[15] OnuoraS. Targeting pDCs in SSc. Nat Rev Rheumatol. 2021; 17(4): 189.

[16] HuangY, LiX, SunX, et al. Anatomical transcriptome atlas of the male mouse reproductive system during aging. Front Cell Dev Biol. 2022; 9: 782824.

[17] ZhangW, LiY, XinS, et al. The emerging roles of IFIT3 in antiviral innate immunity and cellular biology. J Med Virol. 2023; 95(1): e28259.

[18] FrancoJH, Chattopadhyay S, PanZK. How different pathologies are affected by IFIT expression. Viruses. 2023; 15(2): 342.

[19] ShenM, DuanC, XieC, et al. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. Front Immunol. 2022; 13: 962393.

[20] LuoH, ZhouX. Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 infection and primary Sjogren’s syndrome. Front Immunol. 2022; 13: 938837.

[21] HuijserE, Bodewes ILA, LourensMS, et al. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome. Rheumatology (Oxford). 2022; 61(8): 3491-3496.

[22] LiuXY, ChenW, WeiB, ShanYF, WangC. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol. 2011; 187(5): 2559-2568.

[23] MengW, GaoSJ. Targeting XPO1 enhances innate immune response and inhibits KSHV lytic replication during primary infection by nuclear stabilization of the p62 autophagy adaptor protein. Cell Death Dis. 2021; 12(1): 29.

[24] ChikhalyaA, Dittmann M, ZhengY, SohnSY, RiceCM, HearingP. Human IFIT3 protein induces interferon signaling and inhibits adenovirus immediate early gene expression. mBio. 2021; 12(6): e0282921.

[25] JiangM, JiaK, WangL, et al. Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021; 11(10): 2983-2994.

[26] OduroPK, ZhengX, WeiJ, et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022; 12(1): 50-75.

[27] ChenR, DuJ, ZhuH, LingQ. The role of cGAS-STING signalling in liver diseases. JHEP Rep. 2021; 3(5): 100324.

[28] SunY, RevachOY, AndersonS, et al. Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature. 2023; 615(7950): 158-167. doi:10.1038/s41586-023-05704-6

[29] ShaoW, ToddTW, WuY, et al. Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration. Science. 2022; 378(6615): 94-99.

[30] LiuY, XuP, RivaraS, et al. Clathrin-associated AP-1 controls termination of STING signalling. Nature. 2022; 610(7933): 761-767.

[31] ÁlvarezJ, Fernández Real JM, GuarnerF, et al. Gut microbes and health. Microbiota intestinal y salud. Gastroenterol Hepatol. 2021; 44(7): 519-535.

[32] FrangoulH, Altshuler D, CappelliniMD, et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N Engl J Med. 2021; 384(3): 252-260.

[33] SélénouC, Brioude F, GiabicaniE, SobrierML, Netchine I. IGF2: development, genetic and epigenetic abnormalities. Cells. 2022; 11(12): 1886.

[34] ZuoQ, JinK, WangY, Song J, ZhangY, LiB. CRISPR/Cas9-mediated deletion of C1EIS inhibits chicken embryonic stem cell differentiation into male germ cells (Gallus gallus). J Cell Biochem. 2017; 118(8): 2380-2386.

[35] KafajaS, ValeraI, DivekarAA, et al. pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight. 2018; 3(9): e98380.

[36] MahmoudiS, Mancini E, XuL, et al. Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing. Nature. 2019; 574(7779): 553-558.

[37] YangP, LuoQ, WangX, et al. Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases. Am J Respir Crit Care Med. 2023; 207(2): 160-172.

[38] MaL, Hernandez MO, ZhaoY, et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell. 2019; 36(4): 418-430.

[39] ButlerA, Hoffman P, SmibertP, PapalexiE, SatijaR. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018; 36(5): 411-420.

[40] HongM, TaoS, ZhangL, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020; 13(1): 166.

[41] WuY, LiuX, LiG. Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis. Sci Rep. 2022; 12(1): 159.

[42] YunTJ, Igarashi S, ZhaoH, et al. Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells. Sci Immunol. 2021; 6(58): eabc7302.

[43] LippensC, DuraesFV, DubrotJ, et al. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun. 2016; 75: 39-49.

[44] ZhiL, ZhaoL, ZhangX, et al. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging (Albany NY). 2021; 13(18): 22164-22175.

[45] GaoX, BaoW, BaiJ, FanK, LiL, LiY. UHMK1 aids colorectal cancer cell proliferation and chemoresistance through augmenting IL-6/STAT3 signaling. Cell Death Dis. 2022; 13(5): 424.

[46] WangJ, ZhangY, SongH, et al. The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway. Mol Cancer. 2021; 20(1): 81.

[47] ChimSM, QinA, TicknerJ, et al. EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase. J Biol Chem. 2011; 286(25): 22035-22046.

[48] ChenS, MorineY, TokudaK, et al. Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway. Int J Oncol. 2021; 59(2): 59.

[49] MaJD, JingJ, WangJW, et al. A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Res Ther. 2019; 21(1): 153.

[50] MengM, TanJ, ChenW, et al. The fibrosis and immunological features of hypochlorous acid induced mouse model of systemic sclerosis. Front Immunol. 2019; 10: 1861.

[51] WangY, ZhangL, WuGR, et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci Adv. 2021; 7(1): eabb6075.

[52] WangH, XuH, LyuW, et al. KLF4 regulates TERT expression in alveolar epithelial cells in pulmonary fibrosis. Cell Death Dis. 2022; 13(5): 435.

[53] DorstDN, van Caam APM, VittersEL, et al. Fibroblast activation protein targeted photodynamic therapy selectively kills activated skin fibroblasts from systemic sclerosis patients and prevents tissue contraction. Int J Mol Sci. 2021; 22(23): 12681.

[54] LiuX, ZhangP, ZhangX, et al. Fgf21 knockout mice generated using CRISPR/Cas9 reveal genetic alterations that may affect hair growth. Gene. 2020; 733: 144242.

[55] XuM, XuH, ChenJ, Chen C, XuF, QinZ. Generation of conditional Acvrl1 knockout mice by CRISPR/Cas9-mediated gene targeting. Mol Cell Probes. 2018; 37: 32-38.

[56] YanY, DingX, LiK, et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes [published correction appears in Mol Ther. 2014 Dec;22(12):2155]. Mol Ther. 2012; 20(7): 1338-1348. doi:10.1038/mt.2012.12

[57] ParkMJ, ParkY, ChoiJW, et al. Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin. Exp Mol Med. 2022; 54(9): 1577-1585.

[58] XieB, LuC, ChenC, Zhou J, DengZ. miR-135a alleviates silica-induced pulmonary fibrosis by targeting NF-κB/inflammatory signaling pathway. Mediators Inflamm. 2020; 2020: 1231243.

[59] RieppoL, Janssen L, RahunenK, LehenkariP, Finnilä MAJ, SaarakkalaS. Histochemical quantification of collagen content in articular cartilage. PLoS One. 2019; 14(11): e0224839.

[60] ZhangQF, LiJ, JiangK, et al. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner. Theranostics. 2020; 10(23): 10619-10633.

[61] BodewesILA, Huijser E, van Helden-MeeuwsenCG, et al. TBK1: a key regulator and potential treatment target for interferon positive Sjögren’s syndrome, systemic lupus erythematosus and systemic sclerosis. J Autoimmun. 2018; 91: 97-102.

[62] SwieckiM, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015; 15(8): 471-485.

[63] BarratFJ, SuL. A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection. J Exp Med. 2019; 216(9): 1974-1985.

[64] LiG, Larregina AT, DomsicRT, et al. Skin-resident effector memory CD8⁺CD28⁻ T cells exhibit a profibrotic phenotype in patients with systemic sclerosis. J Invest Dermatol. 2017; 137(5): 1042-1050.

[65] PetersMDJ, Godfrey C, McInerneyP, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022; 20(4): 953-968.

[66] ZhaoW. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 2013; 587(6): 542-548.

[67] HeT, XiaY, YangJ. Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect. Pediatr Rheumatol Online J. 2021; 19(1): 9.

[68] LiuG, SunJ, YangZF, et al. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis. 2021; 12(3): 260.

[69] MargaroliC, FramT, SharmaNS, et al. Type I interferon-dependent IFIT3 signaling is critical for viral clearance in airway neutrophils. Res Sq. 2023. doi:10.21203/rs.3.rs-1812836/v1. Preprint. rs.3.rs-1812836.

[70] WangSW, GaoC, ZhengYM, et al. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Mol Cancer. 2022; 21(1): 57.

[71] LiuC, TangJ, LuoW, et al. DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis. Rheumatology (Oxford). 2023; 62(2): 934-945.

[72] BaiZ, GaoT, ZhangR, et al. Inhibition of IL-6 methylation by Saikosaponin C regulates neuroinflammation to alleviate depression. Int Immunopharmacol. 2023; 118: 110043.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.